The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $0.17 in the prior trading day, GlycoMimetics Inc (NASDAQ: GLYC) closed at $0.16, down -5.42%. In other words, the price has decreased by -$5.42 from its previous closing price. On the day, 1.04 million shares were traded.
Ratios:
Our goal is to gain a better understanding of GLYC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.29 and its Current Ratio is at 2.29. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 22, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $12.CapitalOne initiated its Overweight rating on December 22, 2023, with a $12 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’24 when Invus Public Equities, L.P. sold 260,873 shares for $0.19 per share. The transaction valued at 50,009 led to the insider holds 6,317,565 shares of the business.
Invus Public Equities, L.P. sold 61,488 shares of GLYC for $11,197 on Aug 07 ’24. The 10% Owner now owns 6,578,438 shares after completing the transaction at $0.18 per share. On Aug 05 ’24, another insider, Invus Public Equities, L.P., who serves as the 10% Owner of the company, sold 164,523 shares for $0.19 each. As a result, the insider received 30,996 and left with 6,695,658 shares of the company.
Stock Price History:
Over the past 52 weeks, GLYC has reached a high of $0.63, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is -29.57%, while the 200-Day Moving Average is calculated to be -35.98%.
Shares Statistics:
A total of 64.53M shares are outstanding, with a floating share count of 56.12M. Insiders hold about 13.04% of the company’s shares, while institutions hold 43.01% stake in the company.
Earnings Estimates
The stock of GlycoMimetics Inc (GLYC) is currently drawing attention from 1.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between -$0.02 and -$0.02 for the fiscal current year, implying an average EPS of -$0.02. EPS for the following year is -$0.03, with 1.0 analysts recommending between -$0.03 and -$0.03.
